financetom
Business
financetom
/
Business
/
Germany's Merz inaugurates Nvidia supercomputer for research
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Germany's Merz inaugurates Nvidia supercomputer for research
Sep 5, 2025 7:12 AM

BERLIN, Sept 5 (Reuters) - German Chancellor Friedrich

Merz inaugurated a supercomputer powered by Nvidia ( NVDA )

chips on Friday that is the world's fourth-fastest, saying it

helps Europe catch up with the leaders in AI, the United States

and China.

"We are today witnessing a historic European pioneering

project," Merz said at the Juelich research centre in western

Germany, the site of the installation of the Jupiter

supercomputer, which was also assembled by French IT group Atos

and German modular supercomputing company ParTec

.

He said the U.S. and China were leading the race towards an

AI-driven economy, but "we in Germany and in Europe have all the

opportunities to catch up and then to hold our own".

The start of Jupiter's operations marks the first European

supercomputer of the Exascale class, mastering one billion times

one billion calculations per second, also making it the region's

fastest.

That amounts to the power of about 10 million standard

notebook computers.

European institutions are aiming to stay competitive against

the U.S. in supercomputers, used in scientific fields from

biotechnology to climate research, seeking to avoid

over-reliance on digital services from overseas.

Jupiter "will put Germany at the forefront of global

high-performance computing and improve the conditions for the

development of AI," said Ralf Wintergerst, head of digital

business association Bitkom, adding that access to it should be

made as unbureaucratic as possible for start-ups and established

companies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Foremost Up 7% As Reports High-Grade Gold Results from First Two Holes of 2025 Jean Lake Drill Program
Foremost Up 7% As Reports High-Grade Gold Results from First Two Holes of 2025 Jean Lake Drill Program
Nov 10, 2025
10:02 AM EST, 11/10/2025 (MT Newswires) -- Foremost Clean Energy Ltd. ( FMST ) was at last look on Monday morning up 7% on the Canadian Securities Exchange after announcing that it has the receipt of assay results for the first two drillholes, JL25-001 and JL25-002 from its 2025 drill program currently underway at its 100%-owned Jean Lake Gold-Lithium Property...
Form 8.3
Form 8.3
Nov 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Critics call proposed changes to landmark EU privacy law 'death by a thousand cuts'
Critics call proposed changes to landmark EU privacy law 'death by a thousand cuts'
Nov 10, 2025
BRUSSELS, Nov 10 (Reuters) - Privacy activists say proposed changes to Europe's landmark privacy law, including making it easier for Big Tech to harvest Europeans' personal data for AI training, would flout EU case law and gut the legislation. The changes proposed by the European Commission are part of a drive to simplify a slew of laws adopted in recent...
InflaRx Says Phase 2a Data Support Further Development of INF904 in 2 Skin Conditions
InflaRx Says Phase 2a Data Support Further Development of INF904 in 2 Skin Conditions
Nov 10, 2025
10:44 AM EST, 11/10/2025 (MT Newswires) -- InflaRx ( IFRX ) said Monday that a phase 2a study evaluating INF904 in hidradenitis suppurative, or HS, and chronic spontaneous urticaria, or CSU, demonstrated improvements in clinical endpoints, supporting its further development in both indications. Clinical endpoints for HS include reduction in abscesses and nodules, and draining tunnels, which the product candidate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved